Vitamin K2: What It Does, and Who Actually Needs It

01What vitamin K actually is — and why K2 is not just a better version of K1

The K vitamins are fat-soluble compounds grouped by structure, not by a single shared function. Vitamin K1 (phylloquinone) is concentrated in leafy green vegetables and is the primary substrate for blood-clotting factors in the liver. Vitamin K2 (menaquinone) comes in a series of subtypes named by the length of their side chain — MK-4 through MK-13 — with MK-4 and MK-7 being the forms studied most in supplementation research.

K1 and K2 share the same core chemical reaction: they serve as a cofactor for an enzyme that carboxylates (activates) a specific set of proteins. In the liver, those proteins govern clotting. Outside the liver, in bone and the walls of blood vessels, different proteins depend on the same reaction. K2, particularly in the longer-chain MK-7 form, appears to reach extra-hepatic tissues more efficiently and to remain in circulation longer than K1. That difference in tissue distribution is the biochemical basis for most K2 marketing claims — but tissue distribution is a mechanism, not an outcome.

02The two proteins that explain every K2 claim

Almost all the rationale for K2 supplementation traces to two proteins. Osteocalcin is made by bone-forming cells and, when fully carboxylated by K2, is understood to support the binding of calcium into the bone matrix. Matrix Gla protein (MGP) is produced in the walls of blood vessels and cartilage; in its carboxylated, active state it is thought to inhibit calcium deposition in arterial walls.

Both proteins require adequate vitamin K2 to be carboxylated. Studies measuring the ratio of carboxylated to uncarboxylated forms of these proteins confirm that K2 supplementation increases activation — meaning the biochemical step is real and measurable. What is harder to establish is whether that measurable change in protein activation translates into meaningful differences in bone fracture rates or cardiovascular events in people who are not deficient to begin with.

03What the evidence actually shows — and where it stops

In populations with frank K2 deficiency or in specific clinical groups, the evidence is more consistent. Studies in postmenopausal women in Japan — where natto, a fermented soybean food exceptionally high in MK-7, is a dietary staple — found associations between K2 intake and bone health outcomes, but these populations had dietary patterns and baseline K2 levels that are quite different from typical Western diets. Extrapolating those findings to someone in the United States eating varied food is not straightforward.

Supplementation trials in healthy adults with adequate dietary K intake have produced mixed results on bone mineral density, and the effect sizes where benefits are observed tend to be modest. Evidence on arterial calcification in healthy adults is early and not settled — the mechanistic logic is coherent, but large, long-duration randomized trials showing reduced cardiovascular events are not yet available. We do not know whether supplementing K2 in a K-sufficient person produces a clinically meaningful change in hard outcomes. That is an honest summary of where the research stands.

04MK-4 versus MK-7: the form question

MK-4 has a very short half-life in circulation — measured in hours — while MK-7 remains detectable for days. This means MK-7 at a much lower dose (typically 90–200 mcg per day in research) achieves a more sustained tissue presence than the high doses of MK-4 used in some Japanese clinical trials (45 mg per day — a dose more than 200 times larger). Most supplements sold in Western markets use MK-7, often derived from natto extract.

If you are comparing products, the form matters practically. A supplement delivering 100 mcg of MK-7 is not equivalent to one delivering 100 mcg of MK-4; the MK-7 will maintain circulating levels across a 24-hour period more reliably. Whether that sustained presence produces better outcomes than MK-4 in humans has not been directly and definitively studied at matched biologically active doses, so the edge MK-7 holds on pharmacokinetics does not automatically translate to a proven outcome advantage. Our testing and quality page describes how we verify that stated K2 content is actually present, because natto-derived MK-7 is susceptible to degradation.

05Who probably does not need a separate K2 supplement

We sell a product containing K2, so the honest answer here is narrower than the category implies. If you eat green vegetables regularly, some fermented foods, eggs, and dairy from pasture-raised animals, your K2 intake is unlikely to be negligible. If you are under 50, have no identified bone density concern, eat a reasonably varied diet, and are not on a fat-restricted eating pattern that would impair fat-soluble vitamin absorption, the case for supplemental K2 is not compelling based on current evidence.

People who may have a more credible reason to consider K2 include those with established low bone density (in conversation with whoever manages that care), those on long-term antibiotics that disrupt the gut bacteria producing menaquinones endogenously, and those eating diets very low in animal products and fermented foods. Even in these cases, establishing the baseline through diet analysis before purchasing a supplement is a more rational first step than assuming deficiency.

06The warfarin interaction — this is not a footnote

Vitamin K2 directly opposes the mechanism of warfarin and all other vitamin K antagonist anticoagulants. Warfarin works precisely because it blocks the vitamin K recycling enzyme; any supplemental vitamin K — K1 or K2 — competes with that mechanism and can raise INR unpredictably or consistently push it lower than the therapeutic range. This is not a theoretical concern. The interaction is well documented and clinically significant.

If you are on warfarin, acenocoumarol, or any anticoagulant your prescriber described as a vitamin K antagonist, do not add K2 without explicit discussion with your prescriber and pharmacist. This applies to the Vitamin D3 + K2 combination product as much as to standalone K2. For a broader reference on supplement-drug interactions, the article on supplement and medication interactions covers this category in more detail.

07K2 in combination products: what to add up

K2 now appears in bone-support formulas, multivitamins, and vitamin D3 combination products. If you are taking a multivitamin that already contains K2 and a separate bone supplement that also contains K2, the combined dose may be higher than you expect. For most people without warfarin contraindications this is not a safety concern at doses typically found in supplements — but it is worth knowing your total intake, particularly if you are also eating natto or other fermented foods with meaningful K2 content.

The pairing with vitamin D3 has a coherent rationale: vitamin D3 supports calcium absorption, and K2 is proposed to help direct that calcium appropriately. Whether the combination produces better outcomes than vitamin D3 alone in K2-sufficient people has not been clearly established. The article on vitamin D3 and K2 combinations discusses how to read those panels in more detail.

08Dose, upper limits, and what is not established

There is no established Tolerable Upper Intake Level for vitamin K2 because no clear toxicity at high dietary or supplemental doses has been identified in people not taking anticoagulants. This absence of a UL is sometimes read as evidence that more is better — it is not. The absence of an established toxic threshold means the data on high-dose supplementation are limited, not that high doses are confirmed safe. Most research uses MK-7 in the range of 90–360 mcg per day; doses at the higher end of commercially available supplements have not been studied long-term in large populations.

For context on how vitamin K fits within the broader picture of fat-soluble vitamins and their interactions, the supplement upper intake limits reference covers all fat-soluble vitamins together. If you are also taking selenium, note the narrow margin for that mineral — the article on selenium dosing covers the 55 mcg requirement versus the 400 mcg ceiling in detail.

09A cheaper option that deserves naming

Natto — fermented soybeans available at most Asian grocery stores and some larger supermarkets — contains more MK-7 per serving than almost any supplement on the market. A single 100-gram serving can provide several hundred micrograms of MK-7. It is inexpensive and comes with protein, fiber, and other nutrients. The taste is strongly polarizing, but if you are willing to acquire it, natto is the most evidence-aligned dietary source of K2 that exists, and it costs a fraction of a supplement. That is a straightforward fact and worth saying plainly.

For people who will not eat natto, supplemental MK-7 at 90–200 mcg per day is a reasonable approach with a coherent mechanistic basis, particularly when paired with adequate vitamin D status. Checking your vitamin D level before focusing on K2 is also worth considering, since vitamin D deficiency is measurably more common and has a larger evidence base for supplementation.

10Frequently asked questions

what is vitamin k2 mk-7 good for

MK-7 is the longer-chain form of vitamin K2 that stays in circulation for days rather than hours, allowing it to reach bone and vascular tissue more effectively. It participates in activating osteocalcin in bone and matrix Gla protein in arterial walls, both of which are involved in calcium handling. Whether supplementing it in people who already have adequate dietary K intake changes clinical outcomes is less established than the mechanism alone implies.

can i take vitamin k2 with vitamin d3

Yes, and the combination has a plausible rationale — vitamin D3 supports calcium absorption and K2 is proposed to help direct that calcium toward bone rather than soft tissue. However, if you take any anticoagulant medication, particularly warfarin, you must discuss this with your prescriber before taking any form of supplemental vitamin K.

does vitamin k2 cause blood clots

No clear evidence links supplemental K2 at typical doses to increased clotting risk in people not on anticoagulant therapy. The concern in practice runs the other direction: K2 can reduce the effect of anticoagulant drugs like warfarin, potentially lowering anticoagulation in people who need it. Supplemental K2 does not appear to push clotting above normal in people without a clotting disorder.

how much k2 should i take per day

Most research uses MK-7 in the range of 90–200 mcg per day, and this is where the majority of supplementation evidence exists. There is no established Upper Intake Level for vitamin K2 in people without anticoagulant contraindications, but that does not mean higher doses have been confirmed as better — the long-term data at doses above 360 mcg per day are limited.

is vitamin k2 the same as vitamin k

No. Vitamin K is a family of compounds. K1 (phylloquinone) is found mainly in leafy greens and drives liver-based clotting factor production. K2 (menaquinone) comes in multiple subtypes and is more active in bone and vascular tissue. Standard multivitamins often contain only K1; products specifically targeting bone or cardiovascular support may contain K2, and the two forms behave quite differently in the body.

what foods are highest in vitamin k2

Natto (fermented soybeans) is by far the richest source, containing MK-7 in amounts that dwarf most other foods. Hard and soft cheeses, egg yolks, butter from grass-fed animals, chicken liver, and some fermented dairy products contain lower but meaningful amounts of MK-4. If your diet regularly includes these foods, your K2 intake is unlikely to be zero, though probably lower than what natto provides.

can vitamin k2 remove calcium from arteries

This claim exceeds what the evidence supports. Matrix Gla protein, when activated by K2, is understood to inhibit further calcium deposition in arterial walls — but that is a preventive mechanism, not a reversal process. Whether supplemental K2 in humans measurably reduces existing arterial calcification is not established. Early observational data are suggestive; intervention trial data are limited and not conclusive.

does vitamin k2 interact with any medications

The interaction with vitamin K antagonist anticoagulants — warfarin being the most common — is the primary and well-documented concern. K2 directly competes with warfarin's mechanism and can make anticoagulation less effective. Some sources also note potential interactions with certain cholesterol-lowering medications, though the evidence for those interactions is weaker. If you take any prescription medication, checking with a pharmacist before adding K2 is the appropriate step, as the supplement interaction reference explains more broadly.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.